ICU Medical Stock Hits New 52-Week High (ICUI)

NEW YORK ( TheStreet) -- ICU Medical (Nasdaq: ICUI) hit a new 52-week high Friday as it is currently trading at $47.27, above its previous 52-week high of $47.23 with 4,220 shares traded as of 10:40 a.m. ET. Average volume has been 57,400 shares over the past 30 days.

ICU Medical has a market cap of $616.2 million and is part of the health care sector and health services industry. Shares are up 3.4% year to date as of the close of trading on Thursday.

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in vascular therapy, oncology, and critical care applications. The company's product line includes custom intravenous (I.V.) systems, closed delivery systems for hazardous drugs, needleless I.V. The company has a P/E ratio of 17.7, above the average health services industry P/E ratio of 17.1 and equal to the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates ICU Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full ICU Medical Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.